Farther Finance Advisors, LLC

Position in ATYR — aTYR PHARMA INC

CIK 1992825 SAN FRANCISCO, CA

Position in ATYR

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$222

-$807 QoQ

Shares Held

372

-71.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#82

of 90 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. ATYR ranks #246 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$222	372	-71.8%	Shares	Sole	2026-07-17
2026-03-31	$1,029	1,320	-40.7%	Shares	Sole	2026-04-07
2025-12-31	$1,742	2,225	+6.0%	Shares	Sole	2026-01-23
2025-09-30	$1,514	2,100	-89.5%	Shares	Sole	2025-10-14
2025-06-30	$101,009	19,923	-18.4%	Shares	Sole	2025-07-11
2025-03-31	$73,757	24,423	0.0%	Shares	Sole	2025-04-14
2024-12-31	$88,411	24,423	-26.9%	Shares	Sole	2025-02-10
2024-09-30	$58,824	33,423	+9.9%	Shares	Sole	2024-10-29
2024-06-30	$47,459	30,423	+0.3%	Shares	Sole	2024-07-31
2024-03-31	$59,129	30,323	0.0%	Shares	Sole	2024-05-14
2023-12-31	$42,755	30,323	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.